🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,064 results for “BRIGHT” Clear

  1. Combination NRT (Nicotine patch, Nicotine lozenge)

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  2. Danhong injection

    BRIGHT MINDS BIOSCIENCES INC.

    Acute Stroke

    approved small molecule completed

    1 trial

  3. Danhong injection

    BRIGHT MINDS BIOSCIENCES INC.

    Unstable Angina Pectoris

    approved small molecule completed

    1 trial

  4. Desipramine

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  5. Double Blind Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Vaping

    approved small molecule completed

    1 trial

  6. Dronabinol

    BRIGHT MINDS BIOSCIENCES INC.

    Pregnancy Related

    approved small molecule completed

    1 trial

  7. Drug: cimetidine

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    approved small molecule completed

    1 trial

  8. Duragesic reference fentanyl TDS

    BRIGHT MINDS BIOSCIENCES INC.

    Peer Review, Research

    approved small molecule completed

    1 trial

  9. Egg based influenza vaccines

    BRIGHT MINDS BIOSCIENCES INC.

    Influenza

    approved mab active

    1 trial

  10. Electronic Cigarette

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule active

    1 trial

  11. Engerix-B 20 mcg

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved mab completed

    1 trial

  12. Erythromycin 4% topical gel formulation

    BRIGHT MINDS BIOSCIENCES INC.

    Acne Vulgaris

    approved small molecule active

    1 trial

  13. Extended-Release Buprenorphine (XRB)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    1 trial

  14. Extended-Release Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    approved small molecule completed

    1 trial

  15. Fentanyl Injection

    BRIGHT MINDS BIOSCIENCES INC.

    Respiratory Function Loss

    approved small molecule active

    1 trial

  16. Florbetapir F 18 (18F-AV-45)

    BRIGHT MINDS BIOSCIENCES INC.

    Postoperative Cognitive Dysfunction

    approved small molecule active

    1 trial

  17. Fluoxetine

    BRIGHT MINDS BIOSCIENCES INC.

    Body Dysmorphic Disorder

    approved small molecule completed

    1 trial

  18. Fluoxetine + outpatient cognitive behavioral therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol-Related Disorders

    approved small molecule completed

    1 trial

  19. Harvoni (Fixed dose combination ledipasvir/sofosbuvir)

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis C

    approved small molecule completed

    1 trial

  20. Hydrocortisone Acetate 1% Ointment

    BRIGHT MINDS BIOSCIENCES INC.

    Postoperative Sore Throat, Cough, Hoarseness

    approved small molecule active

    1 trial

  21. IIV4 and PPV23

    BRIGHT MINDS BIOSCIENCES INC.

    Influenza, Human

    approved mab completed

    1 trial

  22. Injectable buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    1 trial

  23. Intravenous fentanyl citrate

    BRIGHT MINDS BIOSCIENCES INC.

    Peer Review, Research

    approved small molecule completed

    1 trial

  24. Mailed nicotine replacement therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources